Abdelaziz Alsamarah

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Abnormal alteration of bone morphogenetic protein (BMP) signaling is implicated in many types of diseases including cancer and heterotopic ossifications. Hence, small molecules targeting BMP type I receptors (BMPRI) to interrupt BMP signaling are believed to be an effective approach to treat these diseases. However, lack of understanding of the molecular(More)
  • 1